Study researchers investigated the efficacy of home health deep brain stimulation postoperative management in its ability to reduce travel burden and improve patient access.
The researchers sought to validate self-reported diagnosis of Parkinson disease in a study cohort, assess the validity of other self-reported health information, and evaluate the willingness of participants to participate in video-based research studies.
Researchers examined the efficacy of cervical noninvasive vagus nerve stimulation as an adjunct to standard treatment for patients with Parkinson disease and freezing of gait.
This phase 2, double-blind trial of solriamfetol evaluated the dose-dependent effects on sleep latency in patients with Parkinson disease.
The review authors sought to elucidate the neurological harms of methamphetamine, which are well-documented but poorly understood.
This prospective cohort study assessed whether PD-related brain metabolic patterns may be used as biomarkers in isolated REM sleep behavior disorder.
Studies have identified that patients who engage in exercise had improved symptoms of the disease in addition to higher quality of life, improved balance and mobility, fewer depressive symptoms, and improved thinking skills.
The study researchers reported on a self-assembled hydrogel to deliver the drug 4-dihydroxyphenylalanine (L-DOPA) for Parkinson disease.
Because sargramostim therapeutic use has been offset by dose-dependent adverse events, the researchers performed a reduced drug dose regimen to evaluate safety and to discover novel disease-linked biomarkers during sargramostim treatments for 1 year.
The researchers’ goal studied whether exposure to particulate matters, nitrogen dioxide, ozone, sulfur dioxide, or carbon monoxide raises the risk of Parkinson disease.
